Brief review: rivastigmine, a second cholinesterase inhibitor.
作者信息
Patterson C, Hogan D B
出版信息
Can J Neurol Sci. 2001 Feb;28 Suppl 1:S122-3. doi: 10.1017/s0317167100001293.
PMID:11237306
Abstract
摘要
相似文献
1
Brief review: rivastigmine, a second cholinesterase inhibitor.
Can J Neurol Sci. 2001 Feb;28 Suppl 1:S122-3. doi: 10.1017/s0317167100001293.
2
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Ned Tijdschr Geneeskd. 2003 Apr 5;147(14):679; author reply 679.
3
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Ned Tijdschr Geneeskd. 2003 Apr 5;147(14):679; author reply 679.
4
Understanding changes in cholinergic function: implications for treating dementia.理解胆碱能功能的变化：对治疗痴呆症的意义。
J Clin Psychiatry. 2002 Mar;63(3):259-69. doi: 10.4088/jcp.v63n0316.
5
Rivastigmine for Alzheimer's disease.卡巴拉汀用于治疗阿尔茨海默病。
Drug Ther Bull. 2000 Feb;38(2):15-6.
6
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.长期使用卡巴拉汀治疗路易体痴呆患者：一项开放标签试验。
Int Psychogeriatr. 2001 Jun;13(2):199-205. doi: 10.1017/s104161020100758x.
7
Potential savings in the cost of caring for Alzheimer's disease. Treatment with rivastigmine.
Pharmacoeconomics. 2000 Dec;18(6):609-12. doi: 10.2165/00019053-200018060-00007.
8
Rivastigmine (Exelon) for Alzheimer's disease.卡巴拉汀（艾斯能）用于治疗阿尔茨海默病。
Med Lett Drugs Ther. 2000 Oct 2;42(1089):93-4.
9
10
Drug treatment of Alzheimer's disease and responders to rivastigmine beyond 12 weeks.
Int J Geriatr Psychiatry. 1999 Dec;14(12):1078-9. doi: 10.1002/(sici)1099-1166(199912)14:12<1078::aid-gps73>3.0.co;2-s.
Zotero 插件